Nicole D'Amato, the Chief Legal Officer of InnovAge Holding Corp., has sold 3,402 shares of the company's common stock as part of a pre-established trading plan. This transaction took place on October 22, 2026, and was reported in a recent SEC filing.
The sale of shares is significant as it reflects ongoing stock activity within InnovAge, a company operating in the health services sector. The transaction was executed under a Rule 10b5-1 plan, which allows corporate insiders to set up a predetermined schedule for selling stocks to avoid accusations of insider trading.
Background
InnovAge Holding Corp. is a company focused on providing health services, specifically tailored to meet the needs of seniors. The company is incorporated in Delaware and has its business address in Denver, Colorado. The firm trades under the ticker symbol INNV and is classified under the SIC code for health services.
What the Filing Says
According to the SEC filing (accession number 0001884895-26-000007), D'Amato sold the shares at a weighted average price of $9.51, with individual transactions ranging from $9.50 to $9.525. Following this transaction, D'Amato owns 301,495 shares of InnovAge.
Impact
This sale may influence investor perceptions of InnovAge, particularly regarding insider confidence in the company's stock. The health services sector continues to evolve, and transactions like these can signal various trends to market participants.
What's Next
The filing does not say what happens next.